Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For GLX.SW
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth n.A.
Leverage & Liquidity Balanced
50%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q2 Q4 Δ in %
Current Ratio 5.77 1.53 1.45
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 8.06 -2.41 -2.62
Naive Interpretation member
2 Per Share
Metric Q2 Q4 Δ in %
Book Value 3.98 16.18 15.56
Cash 17.37 3.92 3.34
Capex 17.72 -0.62 -0.75
Free Cash Flow 93.05 0.85 0.44
Revenue 27.14 4.57 3.59
Naive Interpretation member
3 Profitability
Metric Q2 Q4 Δ in %
Gross Margin 6.92 0.77 0.72
Operating Margin 2.43 0.18 0.18
ROA 30.65 0.05 0.03
ROE 30.99 0.06 0.04
ROIC 27.29 0.05 0.04
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of GLX.SW is permitted for members.
5 Growth
The "Growth Entry" for the Focus of GLX.SW is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of GLX.SW is permitted for members.